Grantham, Mayo, Van Otterloo & Co (GMO)’s SiriusPoint SPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-10,900
Closed -$131K 542
2016
Q3
$131K Sell
10,900
-123,343
-92% -$1.53M ﹤0.01% 490
2016
Q2
$1.57M Sell
134,243
-7,457
-5% -$84.7K 0.01% 393
2016
Q1
$1.61M Buy
141,700
+45,800
+48% +$520K 0.01% 386
2015
Q4
$1.29M Buy
95,900
+54,200
+130% +$742K ﹤0.01% 378
2015
Q3
$561K Buy
+41,700
New +$594K ﹤0.01% 460

Other funds holding SPNT

Grantham, Mayo, Van Otterloo & Co (GMO)'s SPNT Position: Q4 2016 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of SiriusPoint (SPNT) in Q4 2016, closing a stake of 10,900 shares — an estimated $131K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SPNT in Q3 2015 and held it in 5 quarters. The position peaked at $1.61M in Q1 2016. 104 funds tracked by Wall St. Rank hold SPNT as of Q4 2016.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining SiriusPoint position as of Q4 2016 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,900 SiriusPoint shares in Q4 2016, an estimated $131K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in SiriusPoint in Q3 2015 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s SiriusPoint position peaked at $1.61M in Q1 2016.
  • 104 funds tracked by Wall St. Rank held SiriusPoint as of Q4 2016.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2016, filed 13 Feb 2017.